Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Liver Transplantation

  Free Subscription


Articles published in Transpl Int

Retrieve available abstracts of 135 articles:
HTML format



Single Articles


    January 2022
  1. LEE CY, Wu MY, Chan HC, Chen TT, et al
    The Influence of Diabetes Mellitus on the Risks of End-Stage Kidney Disease and Mortality After Liver Transplantation.
    Transpl Int. 2022;36:10023.
    PubMed     Abstract available


  2. SANADA Y, Sakuma Y, Onishi Y, Okada N, et al
    Hepatolithiasis After Living Donor Liver Transplantation in Pediatric Patients: Mechanism, Diagnosis, Treatment, and Prognosis.
    Transpl Int. 2022;36:10220.
    PubMed     Abstract available


  3. DALZELL C, Vargas PA, Soltys K, Dipaola F, et al
    Living Donor Liver Transplantation vs. Split Liver Transplantation Using Left Lateral Segment Grafts in Pediatric Recipients: An Analysis of the UNOS Database.
    Transpl Int. 2022;36:10437.
    PubMed     Abstract available


  4. KITANO Y, Pietrasz D, Fernandez-Sevilla E, Golse N, et al
    Subjective Difficulty Scale in Liver Transplantation: A Prospective Observational Study.
    Transpl Int. 2022;35:10308.
    PubMed     Abstract available


  5. SAKAI A, Morishita T, Matsunami H
    Antibody Response After a Second Dose of the BNT162b2 mRNA COVID-19 Vaccine in Liver Transplant Recipients.
    Transpl Int. 2022;35:10321.
    PubMed    


  6. FRIEND P, Pollok JM
    Hypothermic Machine Perfusion in Liver Transplantation-A Randomised Trial and Beyond.
    Transpl Int. 2022;35:10257.
    PubMed    


  7. HERRERO A, Boivineau L, Cassese G, Assenat E, et al
    Progression of AFP SCORE is a Preoperative Predictive Factor of Microvascular Invasion in Selected Patients Meeting Liver Transplantation Criteria for Hepatocellular Carcinoma.
    Transpl Int. 2022;35:10412.
    PubMed     Abstract available


  8. BECKMANN S, Kunzler-Heule P, Kabut K, Mauthner O, et al
    The Main Thing is to be Alive-Exploring Patients' Experiences With Weight Gain After Liver Transplantation: A Qualitative Study.
    Transpl Int. 2022;35:10256.
    PubMed     Abstract available


  9. NEDKOVA-HRISTOVA V, Baliellas C, Gonzalez-Costello J, Llado L, et al
    Treatment With Diflunisal in Domino Liver Transplant Recipients With Acquired Amyloid Neuropathy.
    Transpl Int. 2022;35:10454.
    PubMed     Abstract available


  10. SEEHOFER D, Petrowsky H, Schneeberger S, Vibert E, et al
    Patient Selection for Downstaging of Hepatocellular Carcinoma Prior to Liver Transplantation-Adjusting the Odds?
    Transpl Int. 2022;35:10333.
    PubMed     Abstract available


  11. KIM MS, Hong SK, Woo HY, Cho JH, et al
    Optimal Intervention for Initial Treatment of Anastomotic Biliary Complications After Right Lobe Living Donor Liver Transplantation.
    Transpl Int. 2022;35:10044.
    PubMed     Abstract available


  12. CUK N, Melamed KH, Vangala S, Salah R, et al
    Postoperative Trapped Lung After Orthotopic Liver Transplantation is a Predictor of Increased Mortality.
    Transpl Int. 2022;35:10387.
    PubMed     Abstract available


  13. YAMAGUCHI N, Matsuyama R, Kikuchi Y, Sato S, et al
    Role of the Intramural Vascular Network of the Extrahepatic Bile Duct for the Blood Circulation in the Recipient Extrahepatic Bile Duct Used for Duct-to-Duct-Biliary-Anastomosis in Living Donor Liver Transplantation.
    Transpl Int. 2022;35:10276.
    PubMed     Abstract available


  14. SCHULZ MS, Gu W, Schnitzbauer AA, Trebicka J, et al
    Liver Transplantation as a Cornerstone Treatment for Acute-On-Chronic Liver Failure.
    Transpl Int. 2022;35:10108.
    PubMed     Abstract available


  15. SERRANO MT, Sabroso S, Esteban LM, Berenguer M, et al
    Mortality and Causes of Death After Liver Transplantation: Analysis of Sex Differences in a Large Nationwide Cohort.
    Transpl Int. 2022;35:10263.
    PubMed     Abstract available


  16. DE SIMONE P, Ghinolfi D
    Hospital-Based Health Technology Assessment of Machine Perfusion Systems for Human Liver Transplantation.
    Transpl Int. 2022;35:10405.
    PubMed     Abstract available


  17. HUNT F, Johnston CJC, Coutts L, Sherif AE, et al
    From Haphazard to a Sustainable Normothermic Regional Perfusion Service: A Blueprint for the Introduction of Novel Perfusion Technologies.
    Transpl Int. 2022;35:10493.
    PubMed     Abstract available


  18. GEORGES P, Clerc C, Turco C, Di Martino V, et al
    Post-Transplantation Cytomegalovirus Infection Interplays With the Development of Anastomotic Biliary Strictures After Liver Transplantation.
    Transpl Int. 2022;35:10292.
    PubMed     Abstract available


  19. HANN A, Nutu A, Clarke G, Patel I, et al
    Normothermic Machine Perfusion-Improving the Supply of Transplantable Livers for High-Risk Recipients.
    Transpl Int. 2022;35:10460.
    PubMed     Abstract available


  20. DINGFELDER J, Rauter L, Berlakovich GA, Kollmann D, et al
    Biliary Viability Assessment and Treatment Options of Biliary Injury During Normothermic Liver Perfusion-A Systematic Review.
    Transpl Int. 2022;35:10398.
    PubMed     Abstract available


  21. SMEDMAN TM, Guren TK, Tveit KM, Thomsen M, et al
    Health-Related Quality of Life in Colorectal Cancer Patients Treated With Liver Transplantation Compared to Chemotherapy.
    Transpl Int. 2022;35:10404.
    PubMed     Abstract available


    December 2021
  22. AVOLIO AW, Contegiacomo A, Spoletini G, Moschetta G, et al
    Toward a novel evidence-based definition of early allograft failure in the perspective of liver retransplant.
    Transpl Int. 2021;34:2905-2907.
    PubMed    


  23. KARATOPRAK S, Kutlu R, Karatoprak NB, Dag N, et al
    Percutaneous radiological biliary interventions after failed endoscopic treatment in living liver donors: experience of a high-volume transplantation center.
    Transpl Int. 2021;34:2846-2855.
    PubMed     Abstract available


    November 2021
  24. ORCI LA, Combescure C, Fink M, Oldani G, et al
    Predicting recurrence of hepatocellular carcinoma after liver transplantation using a novel model that incorporates tumor and donor-related factors.
    Transpl Int. 2021 Nov 16. doi: 10.1111/tri.14161.
    PubMed     Abstract available


  25. ABERG F, Abrahamsson J, Schult A, Bennet W, et al
    The RETREAT score provides valid predictions regarding hepatocellular carcinoma recurrence after liver transplantation.
    Transpl Int. 2021 Nov 14. doi: 10.1111/tri.14159.
    PubMed     Abstract available


  26. SNEIDERS D, van Dijk ARM, Polak WG, Mirza DF, et al
    Full-left-full-right split liver transplantation for adult recipients: A systematic review and meta-analysis.
    Transpl Int. 2021 Nov 13. doi: 10.1111/tri.14160.
    PubMed     Abstract available


  27. TEO VXY, Heng RRY, Tay PWL, Ng CH, et al
    A Meta-Analysis on the Prevalence of Chronic Kidney Disease in Liver Transplant Candidates and its Associated Risk Factors and Outcomes.
    Transpl Int. 2021 Nov 13. doi: 10.1111/tri.14158.
    PubMed     Abstract available


  28. LIN J, Ko CJ, Lin KH, Hung YJ, et al
    The Glissonian Stitch Traction for Biliary Duct Manipulation in Living Donor Liver Transplantation.
    Transpl Int. 2021 Nov 8. doi: 10.1111/tri.14155.
    PubMed     Abstract available


  29. BHANJI RA, Chow J, Ma M, Pannu N, et al
    Post liver transplantation chronic kidney disease is associated with increased cardiovascular disease risk and poor survival.
    Transpl Int. 2021 Nov 5. doi: 10.1111/tri.14154.
    PubMed     Abstract available


  30. NUTU OA, Sneiders D, Mirza D, Isaac J, et al
    Safety of intraoperative blood salvage during liver transplantation in patients with hepatocellular carcinoma, a propensity-score matched survival analysis.
    Transpl Int. 2021 Nov 1. doi: 10.1111/tri.14150.
    PubMed     Abstract available


  31. DUELAND S, Smedman TM, Rosok B, Grut H, et al
    Treatment of relapse and survival outcomes after liver transplantation in patients with colorectal liver metastases.
    Transpl Int. 2021;34:2205-2213.
    PubMed     Abstract available


  32. YILMAZ S, Akbulut S, Usta S, Ozsay O, et al
    Diagnostic and therapeutic management algorithm for biliary complications in living liver donors.
    Transpl Int. 2021;34:2226-2237.
    PubMed     Abstract available


  33. FANG W, Noda M, Gotoh K, Morooka Y, et al
    Fatty liver disease in living liver donors: a single-institute experience of 220 donors.
    Transpl Int. 2021;34:2238-2246.
    PubMed     Abstract available


  34. WU G, Liu Y, Rui C, Zhan S, et al
    An oxygenated perfluorocarbon emulsion improves liver graft preservation evaluated in DCD livers of male sprague dawley rats.
    Transpl Int. 2021;34:2087-2097.
    PubMed     Abstract available


  35. CAPELLI R, Kitano Y, Linhares M, Da Silva D, et al
    The prognostic significance of serum aspartate transaminase and gamma-glutamyl transferase in liver deceased donors.
    Transpl Int. 2021;34:2247-2256.
    PubMed     Abstract available


    October 2021
  36. LIM SY, Wang R, Tan DJH, Ng CH, et al
    A Meta-Analysis of the Cumulative Incidence, Risk Factors, and Clinical Outcomes associated with Chronic Kidney Disease after Liver Transplantation.
    Transpl Int. 2021 Oct 29. doi: 10.1111/tri.14149.
    PubMed     Abstract available


    September 2021
  37. YUAN Q, Haque O, Yeh H, Markmann JF, et al
    The impact of race and comorbid conditions on adult liver transplant outcomes in obese recipients.
    Transpl Int. 2021 Sep 27. doi: 10.1111/tri.14125.
    PubMed     Abstract available


  38. IVANICS T, Leonard-Murali S, Mouzaihem H, Moonka D, et al
    Extreme Hyponatremia as a Risk Factor for Early Mortality after Liver Transplantation in the MELD-Sodium Era.
    Transpl Int. 2021 Sep 27. doi: 10.1111/tri.14123.
    PubMed     Abstract available


  39. ANDRES A, Sapisochin G, Nadalin S, Adam R, et al
    Liver transplantation for colorectal liver metastasis: aiming for a cure or a palliation?
    Transpl Int. 2021 Sep 7. doi: 10.1111/tri.14032.
    PubMed     Abstract available


  40. BRIGGS G, Wallace D, Flasche S, Walker K, et al
    Inferior outcomes in young adults undergoing liver transplantation - A UK & ireland cohort study.
    Transpl Int. 2021 Sep 6. doi: 10.1111/tri.14033.
    PubMed     Abstract available


  41. CENTONZE L, Di Sandro S, Lauterio A, De Carlis R, et al
    A retrospective single-centre analysis of the oncological impact of LI-RADS classification applied to Metroticket 2.0 calculator in liver transplantation: every nodule matters.
    Transpl Int. 2021;34:1712-1721.
    PubMed     Abstract available


  42. LANARI J, Hagness M, Sartori A, Rosso E, et al
    Liver transplantation versus liver resection for colorectal liver metastasis: a survival benefit analysis in patients stratified according to tumor burden score.
    Transpl Int. 2021;34:1722-1732.
    PubMed     Abstract available


  43. DE STEFANO N, Navarro-Tableros V, Roggio D, Calleri A, et al
    Human liver stem cell-derived extracellular vesicles reduce injury in a model of normothermic machine perfusion of rat livers previously exposed to a prolonged warm ischemia.
    Transpl Int. 2021;34:1607-1617.
    PubMed     Abstract available


    August 2021
  44. BEKKI Y, Von Ahrens D
    The long-term outcomes in liver transplantation using donation after circulatory death grafts.
    Transpl Int. 2021 Aug 21. doi: 10.1111/tri.14023.
    PubMed     Abstract available


  45. TSIEN C, Selzner N
    PSC Recurrence Post Liver Transplantation: Re-Transplantation justified or not?
    Transpl Int. 2021 Aug 19. doi: 10.1111/tri.14014.
    PubMed     Abstract available


  46. GROTTENTHALER JM, Konzelmann A, Stiegler A, Hinterleitner C, et al
    Significance and clinical impact of routinely tested urinary ethyl glucuronide after liver transplantation - development of a risk score.
    Transpl Int. 2021 Aug 6. doi: 10.1111/tri.14007.
    PubMed     Abstract available


  47. CABALLERO-MARCOS A, Romero-Cristobal M, Puerto M, Fernandez-Yunquera A, et al
    HCV Eradication in Recurrent Hepatitis C after Liver Transplantation Normalizes Enhanced Endothelial Activation.
    Transpl Int. 2021 Aug 3. doi: 10.1111/tri.14000.
    PubMed     Abstract available


    July 2021
  48. PERETZ D, On NH, Miller D, Kim R, et al
    Pharmacokinetics of a Once Daily Tacrolimus Formulation in First Nations and Caucasian Liver Transplant Recipients.
    Transpl Int. 2021 Jul 28. doi: 10.1111/tri.13997.
    PubMed     Abstract available


  49. NG CH, Lim WH, Lim XC, Xiao J, et al
    A Meta-Analysis on the Incidence of Donor Related Depression after Liver Transplant.
    Transpl Int. 2021 Jul 17. doi: 10.1111/tri.13975.
    PubMed     Abstract available


  50. MCDONALD MF, Barrett SC, Malik TH, Anand A, et al
    Elevated Serum Sodium in Recipients of Liver Transplantation Has a Substantial Impact on Outcomes.
    Transpl Int. 2021 Jul 4. doi: 10.1111/tri.13968.
    PubMed     Abstract available


  51. GROTTENTHALER JM, Fuger JK, Mahling M, Konigsrainer A, et al
    Dynamics of glucose metabolism after liver transplantation: Prediabetes as a window of opportunity for patient survival and long-term kidney function.
    Transpl Int. 2021 Jul 2. doi: 10.1111/tri.13967.
    PubMed     Abstract available


    June 2021
  52. AL-KURD A, Kitajima T, Delvecchio K, Shamaa MT, et al
    Short recipient warm ischemia time improves outcomes in deceased donor liver transplantation.
    Transpl Int. 2021 Jun 25. doi: 10.1111/tri.13962.
    PubMed     Abstract available


  53. EMAMAULLEE J, Conrad C, Kim M, Goldbeck C, et al
    Assessment of the Global Practice of Living Donor Liver Transplantation.
    Transpl Int. 2021 Jun 24. doi: 10.1111/tri.13960.
    PubMed     Abstract available


  54. AMYGDALOS I, Bednarsch J, Meister FA, Erren D, et al
    Clinical value and limitations of the preoperative C-reactive-protein-to-albumin ratio in predicting postoperative morbidity and mortality after deceased-donor liver transplantation: a retrospective single-centre study.
    Transpl Int. 2021 Jun 22. doi: 10.1111/tri.13957.
    PubMed     Abstract available


  55. LAUTERIO A, De Carlis R, Valsecchi M, Vella I, et al
    Liver transplantation during the COVID-19 pandemic: a 2020 year-end report from Lombardy, northern Italy.
    Transpl Int. 2021 Jun 18. doi: 10.1111/tri.13953.
    PubMed     Abstract available


  56. CUSUMANO C, De Carlis L, Centonze L, Lesourd R, et al
    Advanced donor age does not increase risk of hepatocellular carcinoma recurrence after liver transplantation: a retrospective two-center analysis using competing risk analysis.
    Transpl Int. 2021 Jun 18. doi: 10.1111/tri.13950.
    PubMed     Abstract available


  57. HANN A, Sneiders D, Hartog H, Perera MTPR, et al
    Commentary on: Short recipient warm ischemia time improves outcomes in deceased donor liver transplantation.
    Transpl Int. 2021 Jun 18. doi: 10.1111/tri.13949.
    PubMed     Abstract available


  58. CAMPOS-VARELA I, Len O, Villagrasa A, Marquez-Algaba E, et al
    Low seroprevalence of SARS-CoV-2 antibodies in a liver transplant cohort.
    Transpl Int. 2021 Jun 14. doi: 10.1111/tri.13946.
    PubMed     Abstract available


    May 2021
  59. VISSEREN T, Erler NS, Polak WG, Adam R, et al
    Recurrence of primary sclerosing cholangitis after liver transplantation - analysing the European Liver Transplant Registry and beyond.
    Transpl Int. 2021 May 24. doi: 10.1111/tri.13925.
    PubMed     Abstract available


  60. UCHIDA H, Sakamoto S, Kasahara M, Ueno Y, et al
    An analysis of the outcomes in living donor liver transplantation for pediatric malignant hepatic tumors using nationwide survey data in Japan.
    Transpl Int. 2021 May 22. doi: 10.1111/tri.13924.
    PubMed     Abstract available


  61. D'AMICO G, Matsushima H, Diago Uso T, Armanyous SR, et al
    Long Term Outcomes and Complications of Reno-portal Anastomosis in Liver Transplantation: Results from a Propensity Score-Based Outcome Analysis.
    Transpl Int. 2021 May 18. doi: 10.1111/tri.13920.
    PubMed     Abstract available


  62. PASSAMONTI SM, Cannavo A, Panigada M, Trunzo V, et al
    Donation after circulatory death (DCD) and liver transplantation: a cohort study.
    Transpl Int. 2021 May 18. doi: 10.1111/tri.13919.
    PubMed     Abstract available


  63. IVANICS T, Shwaartz C, Claasen MPAW, Patel MS, et al
    Trends in Indications and Outcomes of Liver Transplantation in Canada: A Multi Centre Retrospective Study.
    Transpl Int. 2021 May 11. doi: 10.1111/tri.13903.
    PubMed     Abstract available


  64. NITTA H, Younes A, El-Domiaty N, Karam V, et al
    High Trough Levels of Everolimus Combined to Sorafenib Improve Patients Survival After Hepatocellular Carcinoma Recurrence in Liver Transplant Recipients.
    Transpl Int. 2021 May 1. doi: 10.1111/tri.13897.
    PubMed     Abstract available


  65. LAROCHE S, Maulat C, Kitano Y, Golse N, et al
    Initial piggyback technique facilitates late liver retransplantation - a retrospective monocentric study.
    Transpl Int. 2021;34:835-843.
    PubMed     Abstract available


    April 2021
  66. HO OTW, Ng WCA, Ow ZGW, Ho YJ, et al
    Bisphosphonate Therapy after Liver Transplant Improves Bone Mineral Density and Reduces Fracture Rates: An Updated Systematic-Review and Meta-Analysis.
    Transpl Int. 2021 Apr 21. doi: 10.1111/tri.13887.
    PubMed     Abstract available


  67. KELLY WU W, Ziogas IA, Izzy M, Pai AK, et al
    Liver transplantation for congenital hepatic fibrosis.
    Transpl Int. 2021 Apr 20. doi: 10.1111/tri.13884.
    PubMed     Abstract available


  68. LIM WH, Ng CH, Ow ZGW, Ho OTW, et al
    A Systematic Review and Meta-Analysis on the Incidence of Osteoporosis and Fractures after Liver Transplant.
    Transpl Int. 2021 Apr 9. doi: 10.1111/tri.13863.
    PubMed     Abstract available


  69. LEE SA, Hyun J, Yoon YI, Park SY, et al
    Clinical Impact of Mild to Moderate Pulmonary Hypertension in Living-Donor Liver Transplantation.
    Transpl Int. 2021 Apr 2. doi: 10.1111/tri.13875.
    PubMed     Abstract available


  70. LECLAIRE JM, Smith NJ, Chandratre S, Rein L, et al
    Solid organ donor-recipient race-matching: analysis of the United Network for Organ Sharing database.
    Transpl Int. 2021;34:640-647.
    PubMed     Abstract available


    March 2021
  71. MOLINARI M, Carrillo CF, Dongling D, Jorgensen D, et al
    Portal Vein Thrombosis and Renal Dysfunction: A National Comparative Study of Liver Transplant Recipients for NAFLD versus Alcoholic Cirrhosis.
    Transpl Int. 2021 Mar 29. doi: 10.1111/tri.13873.
    PubMed     Abstract available


  72. OZEN J, Beime J, Brinkert F, Fischer L, et al
    Short- and long-term results of liver transplantation according to age at transplant: a single center experience of 351 children.
    Transpl Int. 2021 Mar 27. doi: 10.1111/tri.13872.
    PubMed     Abstract available


  73. CANTU P, Santi G, Rosa R, Parzanese I, et al
    Cost analysis of a long-term randomized controlled study in biliary duct-to-duct anastomotic stricture after liver transplantation.
    Transpl Int. 2021 Mar 17. doi: 10.1111/tri.13867.
    PubMed     Abstract available


  74. LOZANOVSKI VJ, Probst P, Arefidoust A, Ramouz A, et al
    Prognostic role of the Donor Risk Index, the Eurotransplant Donor Risk Index and the Balance of Risk score on graft loss after liver transplantation.
    Transpl Int. 2021 Mar 16. doi: 10.1111/tri.13861.
    PubMed     Abstract available


  75. YOON YI, Song GW, Lee SG, Park GC, et al
    Safe Use of Right Lobe Living Donor Livers with Moderate Steatosis in Adult-to-adult Living Donor Liver Transplantation: A Retrospective Study.
    Transpl Int. 2021 Mar 4. doi: 10.1111/tri.13859.
    PubMed     Abstract available


  76. MAZZOTTA AD, Pascale A, Cano L, Rosmorduc O, et al
    Number Of HCC Nodules in Patients Listed for Liver Transplantation Within Alpha-Fetoprotein Score : a New Prognostic Risk Factor.
    Transpl Int. 2021 Mar 3. doi: 10.1111/tri.13858.
    PubMed     Abstract available


    February 2021
  77. AKAMATSU N, Hasegawa K, Egawa H, Ohdan H, et al
    Donor age (>/= 45 years) and reduced immunosuppression are associated with the recurrent primary sclerosing cholangitis after liver transplantation - a multicenter retrospective study.
    Transpl Int. 2021 Feb 24. doi: 10.1111/tri.13852.
    PubMed     Abstract available


  78. SASAKI K, Nair A, Firl DJ, McVey JC, et al
    Conditional Probability of Graft Survival in Liver Transplantation using Donation after Circulatory Death grafts - a retrospective study.
    Transpl Int. 2021 Feb 17. doi: 10.1111/tri.13846.
    PubMed     Abstract available


  79. GAMBATO M, Germani G, Perini B, Gringeri E, et al
    A challenging liver transplantation for decompensated alcoholic liver disease after recovery from SARS-CoV-2 infection.
    Transpl Int. 2021 Feb 8. doi: 10.1111/tri.13842.
    PubMed     Abstract available


  80. ABDELAZIZ O, Osman AMA, Hosny KA, Emad-Eldin S, et al
    Management of Early Hepatic Artery Thrombosis following Living-Donor Liver Transplantation: Feasibility, Efficacy and Potential Risks of Endovascular Therapy in the First 48 Hours Post-Transplant.
    Transpl Int. 2021 Feb 4. doi: 10.1111/tri.13839.
    PubMed     Abstract available


  81. WANIS KN, Sarvet A, Ruffolo LI, Levstik MA, et al
    Estimating the effect of increasing utilization of living donor liver transplantation using observational data.
    Transpl Int. 2021 Feb 1. doi: 10.1111/tri.13835.
    PubMed     Abstract available


    January 2021
  82. SHALABY S, Taborelli M, Zanetto A, Ferrarese A, et al
    Hepatocellular carcinoma and the risk of de novo malignancies after liver transplantation.
    Transpl Int. 2021 Jan 25. doi: 10.1111/tri.13831.
    PubMed     Abstract available


  83. CHEN M, Chen Z, Lin X, Hong X, et al
    Application of Ischemia-Free Liver Transplantation Improves Prognosis of Patients with Steatotic Donor Livers.
    Transpl Int. 2021 Jan 23. doi: 10.1111/tri.13828.
    PubMed     Abstract available


  84. LOZANOVSKI VJ, Probst P, Ramouz A, Arefidoust A, et al
    Considering Extended Right Lobe grafts as major Extended Donor Criteria in liver transplantation is justified.
    Transpl Int. 2021 Jan 20. doi: 10.1111/tri.13824.
    PubMed     Abstract available


  85. RICHARDS JA, Randle LV, Butler MChir AJ, Martin JL, et al
    Pilot study of a non-invasive real-time optical backscatter probe in liver transplantation.
    Transpl Int. 2021 Jan 19. doi: 10.1111/tri.13823.
    PubMed     Abstract available


  86. MOURAD M, Lebosse F, Merle P, Levrero M, et al
    External validation of the French AFP model for HCC liver transplantation in a recent unicentric cohort.
    Transpl Int. 2021 Jan 15. doi: 10.1111/tri.13819.
    PubMed     Abstract available


  87. FERRARESE A, Sartori G, Orru G, Frigo AC, et al
    Machine Learning in Liver Transplantation: a tool for some unsolved questions?
    Transpl Int. 2021 Jan 11. doi: 10.1111/tri.13818.
    PubMed     Abstract available


  88. NAGAI S, Safwan M, Kitajima T, Yeddula S, et al
    Disease-Specific Waitlist Outcomes in Liver Transplantation.
    Transpl Int. 2021 Jan 10. doi: 10.1111/tri.13814.
    PubMed     Abstract available


  89. THOMPSON ER, Connelly C, Ali S, Sheerin NS, et al
    Cell therapy during machine perfusion.
    Transpl Int. 2021;34:49-58.
    PubMed     Abstract available


  90. PU X, He D, Liao A, Yang J, et al
    A Novel Strategy for Preventing Posttransplant Large-For-Size Syndrome in Adult Liver Transplant Recipients: A Pilot Study.
    Transpl Int. 2022;35:10177.
    PubMed     Abstract available


  91. ALEXOPOULOS SP, Wu WK, Ziogas IA, Matsuoka LK, et al
    Adult Combined Heart-Liver Transplantation: The United States Experience.
    Transpl Int. 2022;35:10036.
    PubMed     Abstract available


    December 2020
  92. WOO HY, Hong SK, Cho JH, Lee JM, et al
    Complications of Polytetrafluoroethylene Graft-Use in Middle Hepatic Vein Reconstruction in Living Donor Liver Transplantation: A Retrospective, Single-Center, Long-Term, Real-World Experience.
    Transpl Int. 2020 Dec 23. doi: 10.1111/tri.13807.
    PubMed     Abstract available


  93. SCHOENBERG MB, Ehmer U, Umgelter A, Bucher JN, et al
    Liver Transplantation versus Watchful-Waiting in Hepatocellular Carcinoma Patients with Complete Response to Bridging-Therapy.
    Transpl Int. 2020 Dec 23. doi: 10.1111/tri.13808.
    PubMed     Abstract available


  94. DI SANDRO S, Magistri P, Bagnardi V, Catellani B, et al
    The Covid-19 second wave risk and liver transplantation: lesson from the recent past and the unavoidable need of living donors.
    Transpl Int. 2020 Dec 18. doi: 10.1111/tri.13803.
    PubMed     Abstract available


  95. MA L, Li M, Zhang T, Xu JQ, et al
    Incidence of de novo autoimmune hepatitis in children and adolescents with increased autoantibodies after liver transplantation: a meta-analysis.
    Transpl Int. 2020 Dec 14. doi: 10.1111/tri.13801.
    PubMed     Abstract available


  96. VAN DEN EYNDE J, Achtergaele J, Fieuws S, Jochmans I, et al
    The effect of organ preservation solutions on short-term outcomes after liver transplantation: a single-centre retrospective study.
    Transpl Int. 2020 Dec 6. doi: 10.1111/tri.13799.
    PubMed     Abstract available


  97. POLAK WG, Fondevila C, Karam V, Adam R, et al
    Reply to Rodriguez-Peralvarez et al.
    Transpl Int. 2020;33:1825-1826.
    PubMed    


  98. MANGIONI D, Dondossola D, Antonelli B, Alagna L, et al
    Coronavirus disease 2019 and transplantation: tackling the challenges of SARS-CoV-2 infection in waiting list candidates.
    Transpl Int. 2020;33:1830-1832.
    PubMed    


    November 2020
  99. RAUT V, Sonavane A, Shah K, Amruthraj C, et al
    Successful liver transplantation immediately after recovery from COVID-19 in a highly endemic area.
    Transpl Int. 2020 Nov 30. doi: 10.1111/tri.13790.
    PubMed     Abstract available


  100. RHU J, Kim JM, Jeong WK, Choi GS, et al
    Venous outflow congestion is related to poor recurrence-free survival of living donor liver transplantation recipients with hepatocellular carcinoma.
    Transpl Int. 2020 Nov 30. doi: 10.1111/tri.13792.
    PubMed     Abstract available


  101. NAVEZ J, Iesari S, Kourta D, Baami-Mariza K, et al
    The real incidence of biliary tract complications after adult liver transplantation: the role of the prospective routine use of cholangiography during post-transplant follow-up.
    Transpl Int. 2020 Nov 14. doi: 10.1111/tri.13786.
    PubMed     Abstract available


  102. NAM NH, Taura K, Yao S, Kaido T, et al
    Pretransplantation splenomegaly frequently persists after liver transplantation and can manifest as hypersplenism and graft fibrosis - a retrospective study.
    Transpl Int. 2020 Nov 9. doi: 10.1111/tri.13761.
    PubMed     Abstract available


  103. VISSEREN T, Fuhler GM, Erler NS, Nossent YRA, et al
    Recurrence of primary sclerosing cholangitis after liver transplantation is associated with specific changes in the gut microbiome pretransplant - a pilot study.
    Transpl Int. 2020;33:1424-1436.
    PubMed     Abstract available


    October 2020
  104. MEMARAN N, Kupper C, Borchert-Morlins B, von Wick A, et al
    Prospective Assessment of Subclinical Cardiovascular Damage and Associated Factors in Liver Transplant Recipients.
    Transpl Int. 2020 Oct 18. doi: 10.1111/tri.13773.
    PubMed     Abstract available


  105. IZZY M, Angirekula M, Bentall A, Plevak M, et al
    Role Of Symmetric Dimethylarginine In Predicting Future Renal Impairment In Liver Transplant Recipients.
    Transpl Int. 2020 Oct 17. doi: 10.1111/tri.13771.
    PubMed     Abstract available


  106. BRUGGENWIRTH IMA, van Reeven M, Vasiliauskaite I, van der Helm D, et al
    Donor diabetes mellitus is a risk factor for diminished outcome after liver transplantation: a nationwide retrospective cohort study.
    Transpl Int. 2020 Oct 17. doi: 10.1111/tri.13770.
    PubMed     Abstract available


  107. PINERO F, Anders M, Boin IF, Chagas A, et al
    Liver transplantation for hepatocellular carcinoma: impact of expansion criteria in a multicenter cohort study from a high waitlist mortality region."
    Transpl Int. 2020 Oct 11. doi: 10.1111/tri.13767.
    PubMed     Abstract available


  108. DE CARLIS R, Buscemi V, Checchini G, Frassoni S, et al
    Liver transplantation from brain-dead donors on mechanical circulatory support: a systematic review of the literature.
    Transpl Int. 2020 Oct 9. doi: 10.1111/tri.13766.
    PubMed     Abstract available


  109. MELANDRO F, Ghinolfi D, Balzano E, Tincani G, et al
    Light at the end of the tunnel: COVID-19 lockdown has not halted liver transplantation at a high volume center in Italy.
    Transpl Int. 2020 Oct 8. doi: 10.1111/tri.13764.
    PubMed     Abstract available


  110. KOVANDOVA B, Slavcev A, Honsova E, Erhartova D, et al
    De Novo HLA Class II Antibodies Are Associated with the Development of Chronic but not Acute Antibody-Mediated Rejection after Liver Transplantation.
    Transpl Int. 2020 Oct 5. doi: 10.1111/tri.13763.
    PubMed     Abstract available


  111. BOFFINI M, Pidello S, Simonato E, Barbero C, et al
    An effective protocol for heart transplantation during COVID-19 outbreak.
    Transpl Int. 2020;33:1326-1328.
    PubMed    


    September 2020
  112. CHOI D, Liu M, Guttikonda D, Galen K, et al
    Recipient Risk Factors for Acute Cellular Rejection After Orthotopic Liver Transplant.
    Transpl Int. 2020 Sep 29. doi: 10.1111/tri.13756.
    PubMed     Abstract available


  113. IMAOKA Y, Ohira M, Sato K, Kuroda S, et al
    Impact of Donor Abdominal Aortic Calcification among Living Donor Liver Transplant Donors: A Retrospective Study.
    Transpl Int. 2020 Sep 24. doi: 10.1111/tri.13748.
    PubMed     Abstract available


  114. LEVI SANDRI GB, Berardi G, Giannelli V, Ettorre GM, et al
    Primary role of Radioembolization as a downstaging strategy in patients with macrovascular invasion prior to liver transplantation.
    Transpl Int. 2020 Sep 15. doi: 10.1111/tri.13746.
    PubMed     Abstract available


  115. MAHALE P, Mckenna GJ, Saracino G, Jennings L, et al
    Hypomagnesemia and risk of post-transplant lymphoproliferative disorder in liver transplant recipients.
    Transpl Int. 2020 Sep 7. doi: 10.1111/tri.13735.
    PubMed     Abstract available


  116. RODRIGUEZ-PERALVAREZ M, Salcedo M, Colmenero J, Pons JA, et al
    Increased incidence of Covid-19 among liver transplant patients in Europe.
    Transpl Int. 2020 Sep 2. doi: 10.1111/tri.13729.
    PubMed     Abstract available


  117. PASCALE MM, Bianco G, Ferri L, Agnes S, et al
    COVID-19 health restrictions in a transplanted Italian cohort.
    Transpl Int. 2020;33:1151-1153.
    PubMed    


  118. SHI H, Xu J, Li X, Zhao Y, et al
    First organ donation in Wuhan after ending of the coronavirus lockdown.
    Transpl Int. 2020;33:1149-1150.
    PubMed    


    August 2020
  119. WIJARNPREECHA K, Pungpapong S, Aby ES, Croome KP, et al
    Simultaneous liver transplant and sleeve gastrectomy not associated with worse index admission outcomes compared to liver transplant alone.
    Transpl Int. 2020 Aug 9. doi: 10.1111/tri.13713.
    PubMed     Abstract available


  120. LERUT J, Karam V, Cailliez V, Bismuth H, et al
    What did the European Liver Transplant Registry (ELTR) Bring to Liver Transplantation?
    Transpl Int. 2020 Aug 7. doi: 10.1111/tri.13716.
    PubMed     Abstract available


    July 2020
  121. PRAVISANI R, Hidaka M, Baccarani U, Ono S, et al
    Effect of pre-transplant sarcopenia on the estimation of standard liver volume in living-donor liver transplant candidates: risk factor for post-transplant small for size syndrome?
    Transpl Int. 2020 Jul 4. doi: 10.1111/tri.13690.
    PubMed     Abstract available


  122. POLAK WG, Fondevila C, Karam V, Adam R, et al
    Impact of COVID-19 on liver transplantation in Europe: Alert from an early survey of European Liver and Intestine Transplantation Association (ELITA) and European Liver Transplant Registry (ELTR).
    Transpl Int. 2020 Jul 1. doi: 10.1111/tri.13680.
    PubMed     Abstract available


    June 2020
  123. LEVESQUE E, Lim C, Feray C, Salloum C, et al
    Liver Transplantation in Patients with Sickle Cell Disease: possible but challenging.
    Transpl Int. 2020 Jun 7. doi: 10.1111/tri.13669.
    PubMed     Abstract available


    April 2020
  124. LAUTERIO A, De Carlis R, Belli L, Fumagalli R, et al
    How to guarantee liver transplantation in the north of Italy during the COVID-19 pandemic. A sound transplant protection strategy.
    Transpl Int. 2020 Apr 29. doi: 10.1111/tri.13633.
    PubMed     Abstract available


  125. WERNER JM, Hornung M, Krah R, Gotz M, et al
    HCC recurrence in HCV patients after liver transplantation: SiLVER Study reveals benefits of sirolimus in combination with CNIs.
    Transpl Int. 2020 Apr 21. doi: 10.1111/tri.13621.
    PubMed     Abstract available


  126. ISMAIL MS, Hassan M, Martinez-Camacho A, May SB, et al
    Retrospective analysis of long-term outcome 10 years after liver transplantation for Wilson disease: experience over three decades.
    Transpl Int. 2020 Apr 21. doi: 10.1111/tri.13622.
    PubMed     Abstract available


  127. HESSHEIMER AJ, Gastaca M, Minambres E, Colmenero J, et al
    Donation after circulatory death liver transplantation: consensus statements from the spanish liver transplantation society.
    Transpl Int. 2020 Apr 20. doi: 10.1111/tri.13619.
    PubMed     Abstract available


    January 2020
  128. ASSALINO M, Terraz S, Grat M, Lai Q, et al
    Liver transplantation for hepatocellular carcinoma after successful treatment of macrovascular invasion.
    Transpl Int. 2020 Jan 28. doi: 10.1111/tri.13586.
    PubMed     Abstract available


  129. AL-AMERI AAM, Wei X, Wen X, Wei Q, et al
    Systematic Review: Risk Prediction Models for Recurrence of Hepatocellular Carcinoma after Liver Transplantation.
    Transpl Int. 2020 Jan 27. doi: 10.1111/tri.13585.
    PubMed     Abstract available


    December 2019
  130. LAW JH, Tan NCH, Kow AWC
    Letter to Editor - Initial Experience of Laparoscopic Living Donor Hepatectomy for Pediatric Liver Transplantation in a Southeast Asian Transplant Center.
    Transpl Int. 2019 Dec 23. doi: 10.1111/tri.13565.
    PubMed     Abstract available


    October 2019
  131. YAZAWA M, Cseprekal O, Helmick RA, Talwar M, et al
    Association Between Post-Transplant Donor Specific Antibodies and Recipient Outcomes in Simultaneous Liver-Kidney Transplant Recipients: single center, cohort study.
    Transpl Int. 2019 Oct 24. doi: 10.1111/tri.13543.
    PubMed     Abstract available


    September 2019
  132. LAUTERIO A, De Carlis R, Di Sandro S, Buscemi V, et al
    Delayed kidney transplantation in combined liver-kidney transplantation for polycystic liver and kidney disease.
    Transpl Int. 2019 Sep 27. doi: 10.1111/tri.13537.
    PubMed     Abstract available


    June 2019
  133. HILLEBRANDT KH, Everwien H, Haep N, Keshi E, et al
    Strategies based on organ decellularization and recellularization.
    Transpl Int. 2019;32:571-585.
    PubMed     Abstract available


  134. WEISSENBACHER A, Vrakas G, Nasralla D, Ceresa CDL, et al
    The future of organ perfusion and re-conditioning.
    Transpl Int. 2019;32:586-597.
    PubMed     Abstract available


    April 2019
  135. MINNEE RC, Darwish Murad S, Polak WG, Metselaar HJ, et al
    Combined liver-kidney transplantation; two for the price of one?
    Transpl Int. 2019 Apr 8. doi: 10.1111/tri.13438.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Transplantation is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: